StockClub

TRAW

TRAWTraws Pharma, Inc.$ --
Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q2
Revenue
0M USD
YoY -100.0%
Operating Income
-7M USD
YoY -456.1%
Net Income
-7M USD
YoY -676.7%
EPS
-0.53$
YoY -381.8%

Revenue

$0
FY2022 Q4$226,000
$226,000
Q4
FY2023 Q2$113,000
$113,000
Q2
FY2023 Q4$226,000
$226,000
Q4
FY2024 Q2$56,000
$56,000
Q2
FY2024 Q4$113,000
$113,000
Q4
FY2025 Q2$2.7M
$2.7M
Q2
FY2025 Q4$2.7M
$2.7M
Q4
FY2026 Q2$0
$0
Q2
Actual
$-2.7M (-100.0%)

Net Income

$-7.1M
FY2022 Q4$-19M
$-19M
Q4
FY2023 Q2$-10M
$-10M
Q2
FY2023 Q4$-18.9M
$-18.9M
Q4
FY2024 Q2$-5M
$-5M
Q2
FY2024 Q4$-13.5M
$-13.5M
Q4
FY2025 Q2$-915,000
$-915,000
Q2
FY2025 Q4$-8.4M
$-8.4M
Q4
FY2026 Q2$-7.1M
$-7.1M
Q2
Actual
$-6.2M (-676.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$231,000
Est:$210,750
FY2020BEAT
$231,000
FY2021MISS
Actual:$226,000
Est:$232,000
FY2021MISS
$226,000
FY2022BEAT
Actual:$226,000
Est:$207,500
FY2022BEAT
$226,000
FY2023BEAT
Actual:$226,000
Est:$215,333
FY2023BEAT
$226,000
FY2024MISS
Actual:$226,000
Est:$230,000
FY2024MISS
$226,000
FY2025MISS
Actual:$2.8M
Est:$2.8M
FY2025MISS
$2.8M

Analyst Estimates